Lestradet H
Ann Pediatr (Paris). 1991 Apr;38(4):229-34.
Enzymatic glycosylation of proteins should be clearly distinguished from non-enzymatic glycosylation or glycation. Both processes occur in normal subjects but are enhanced in patients with hyperglycemia. Increased enzymatic glycation in patients with diabetes mellitus is responsible for thickening and weakening of capillary membranes, resulting in microangiopathy with microaneurisms, bleeding, and circulatory exclusion. Non-enzymatic glycosylation (glycation) affects all the proteins in the body and, if intense enough, may modify the activity or effectiveness of some molecules (apolipoproteins, membrane receptors, or even insulin itself). In everyday practice, glycated serum albumin and, above all, glycated hemoglobin serve as markers to evaluate the effectiveness of therapy in patients with diabetes mellitus.
蛋白质的酶促糖基化应与非酶促糖基化或糖基化终产物形成明确区分。这两个过程在正常个体中都会发生,但在高血糖患者中会增强。糖尿病患者体内酶促糖基化增加会导致毛细血管膜增厚和变薄,从而引发伴有微动脉瘤、出血和循环障碍的微血管病变。非酶促糖基化(糖基化终产物)会影响体内所有蛋白质,若程度足够严重,可能会改变某些分子(载脂蛋白、膜受体,甚至胰岛素本身)的活性或效能。在日常临床实践中,糖化血清白蛋白,尤其是糖化血红蛋白可作为评估糖尿病患者治疗效果的指标。